Sprint Bioscience AB (SPRINT) — Cash Flow Quality Index
Sprint Bioscience AB (SPRINT) has a Cash Flow Quality Index of 1.02x as of December 2025. Operating cash flow of Skr115.84 Million exceeds net income of Skr113.17 Million, indicating high earnings quality where cash backs reported profits. Also explore SPRINT total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sprint Bioscience AB Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Sprint Bioscience AB across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Sprint Bioscience AB tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sprint Bioscience AB (2016–2025)
Year-by-year earnings quality comparison for Sprint Bioscience AB. For live market cap and the full company financial profile, see Sprint Bioscience AB market cap and net worth.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.91x | Skr83.53 Million | Skr91.74 Million | ▼ -47.6% |
| 2016 | 1.74x | Skr7.93 Million | Skr4.57 Million | — |